Nerviano and Italfarmaco Announce Licensing of Linker-Payload Technology
14 Dec 2023 //
BUSINESSWIRE
Nerviano Medical Sciences Presents Phase 1 Data for PARP-1 Selective Inhibitor
12 Oct 2023 //
BUSINESSWIRE
Nerviano Medical to Present Preliminary Phase 1 PARP1 selective inhibitor data
02 Oct 2023 //
BUSINESSWIRE
Nerviano Medical Sciences Announces Enhanced US Executive Team
01 Aug 2023 //
BUSINESSWIRE
Nerviano Medical Sciences Announces Licensing of Linker-Payload Technology
05 Jun 2023 //
PR NEWSWIRE
Nerviano Medical Sciences Strengthens Executive Team to Maximize IDH1/IDH2 Asset
12 Jan 2023 //
BUSINESSWIRE